European Capital Markets Forum highlights Market players must tread carefully to capitalise on policymakers’ efforts to revive the regional economy By Danielle Myles & Tom Young April 22 2015
It’s time regulators listened on Mifid II It’s crunch time for the revised Markets in Financial Instruments Directive. Esma must heed the industry’s concerns over liquidity, costs and access to prevent disaster in 2017 By Tom Young April 22 2015
European IPO pre-marketing faces ‘investor fatigue’ The increasingly early marketing practices featuring on European IPOs could lead to investor backlash if deal volume continues to rise By Tom Young April 15 2015
EM issuers should steer clear of portability The debate surrounding the usefulness of portability clauses in European high-yield continues, with one in-house counsel at IFLR’s Capital Markets Forum insisting it has no place in emerging market corporate-led... By Tom Young April 15 2015
Pro-seller M&A structures on the rise Sellers in European M&A deals took on less risk in 2014 as the region saw a major uplift in M&A deal value, according to a study by CMS Cameron McKenna... By Tom Young March 31 2015
White list concerns exacerbated by cov-lite growth Opposition to white lists is growing as the rise of cov-lite deals exposes investors further to the practice. But the feature is expected to linger until deal volumes start outweighing... By Tom Young March 17 2015
FCA threatens binding rules over structured products The regulator's review of structured product governance has criticised the ways in which the instruments are developed and sold. By Tom Young March 17 2015
Europe high-yield investors’ letter unpicked Buyside have written another letter outlining their six key concerns within the asset class. Here, issuers' counsel and bankers' respond By Tom Young March 05 2015
